Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study.

Palli E, Makris D, Papanikolaou J, Garoufalis G, Tsilioni I, Zygoulis P, Zakynthinos E.

Crit Care. 2017 Oct 31;21(1):269. doi: 10.1186/s13054-017-1862-3.

2.

Role of serum cystatin-C and beta-2 microglobulin as early markers of renal dysfunction in children with beta thalassemia major.

Behairy OG, Abd Almonaem ER, Abed NT, Abdel Haiea OM, Zakaria RM, AbdEllaty RI, Asr EH, Mansour AI, Abdelrahman AM, Elhady HA.

Int J Nephrol Renovasc Dis. 2017 Sep 11;10:261-268. doi: 10.2147/IJNRD.S142824. eCollection 2017.

3.

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

Bucsics T, Krones E.

Gastroenterol Rep (Oxf). 2017 May;5(2):127-137. doi: 10.1093/gastro/gox009. Epub 2017 Apr 24.

4.

Circulating Angiopoietin-2 and Its Soluble Receptor Tie-2 Concentrations Are Related to Renal Function in Two Population-Based Cohorts.

Hennings A, Hannemann A, Rettig R, Dörr M, Nauck M, Völzke H, Lerch MM, Lieb W, Friedrich N.

PLoS One. 2016 Nov 28;11(11):e0166492. doi: 10.1371/journal.pone.0166492. eCollection 2016. Erratum in: PLoS One. 2017 Apr 19;12 (4):e0176477.

5.

Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats.

Ghys LF, Paepe D, Lefebvre HP, Reynolds BS, Croubels S, Meyer E, Delanghe JR, Daminet S.

J Vet Intern Med. 2016 Jul;30(4):1074-82. doi: 10.1111/jvim.14256.

6.

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

Shin JE, Lee SM, Eun HS, Park MS, Park KI, Namgung R.

Korean J Pediatr. 2015 Nov;58(11):421-6. doi: 10.3345/kjp.2015.58.11.421. Epub 2015 Nov 22.

7.

The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis.

Krones E, Fickert P, Zitta S, Neunherz S, Artinger K, Reibnegger G, Durchschein F, Wagner D, Stojakovic T, Stadlbauer V, Fauler G, Stauber R, Zollner G, Kniepeiss D, Rosenkranz AR.

BMC Nephrol. 2015 Dec 1;16:196. doi: 10.1186/s12882-015-0188-0.

8.

Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients: The first experience in Iran.

Javanmardi M, Azadi NA, Amini S, Abdi M.

J Res Med Sci. 2015 Jun;20(6):571-6. doi: 10.4103/1735-1995.165960.

9.

Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study.

Kulcsar-Jakab E, Petho Z, Pap Z, Kalina E, Foldesi R, Balogh A, Antal-Szalmas P, Bhattoa HP.

BMC Musculoskelet Disord. 2015 Aug 28;16:227. doi: 10.1186/s12891-015-0684-1.

10.

Serum Cystatin C for the Diagnosis of Acute Kidney Injury in Patients Admitted in the Emergency Department.

Bongiovanni C, Magrini L, Salerno G, Gori CS, Cardelli P, Hur M, Buggi M, Di Somma S.

Dis Markers. 2015;2015:416059. doi: 10.1155/2015/416059. Epub 2015 Jun 15.

11.

Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.

Rodieux F, Wilbaux M, van den Anker JN, Pfister M.

Clin Pharmacokinet. 2015 Dec;54(12):1183-204. doi: 10.1007/s40262-015-0298-7. Review.

12.

Can cystatin C become an easy and reliable tool for anesthesiologists to calculate glomerular filtration rate?

Aulakh NK, Bansal E, Bose A, Aulakh GS, Aulakh BS, Singh MR.

J Anaesthesiol Clin Pharmacol. 2015 Jan-Mar;31(1):44-8. doi: 10.4103/0970-9185.150538.

13.

Cystatin C as a potential biomarker for dosing of renally excreted drugs.

Brou NA, Jacqz-Aigrain E, Zhao W.

Br J Clin Pharmacol. 2015 Jul;80(1):20-7. doi: 10.1111/bcp.12602. Epub 2015 May 28. Review.

14.

Estimation of renal function in the intensive care unit: the covert concepts brought to light.

Sunder S, Jayaraman R, Mahapatra HS, Sathi S, Ramanan V, Kanchi P, Gupta A, Daksh SK, Ram P.

J Intensive Care. 2014 May 7;2(1):31. doi: 10.1186/2052-0492-2-31. eCollection 2014. Review.

15.

Cystatin C and serum creatinine in estimating acute kidney injury of shock patients.

Li Q, Fang JY, Wang WP, Liu JH, Wang KK.

World J Emerg Med. 2010;1(3):185-9.

16.

Proteinuria, (99m) Tc-DTPA Scintigraphy, Creatinine-, Cystatin- and Combined-Based Equations in the Assessment of Chronic Kidney Disease.

Trimarchi H, Muryan A, Toscano A, Martino D, Forrester M, Pomeranz V, Lombi F, Young P, Raña MS, Karl A, Alonso M, Dicugno M, Fitzsimons C.

ISRN Nephrol. 2014 Feb 11;2014:430247. doi: 10.1155/2014/430247. eCollection 2014.

17.

Delineation of concentration ranges and longitudinal changes of human plasma protein variants.

Trenchevska O, Phillips DA, Nelson RW, Nedelkov D.

PLoS One. 2014 Jun 23;9(6):e100713. doi: 10.1371/journal.pone.0100713. eCollection 2014.

18.

Folate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease.

Somers EB, O'Shannessy DJ.

Biomark Insights. 2014 May 25;9:29-37. doi: 10.4137/BMI.S15245. eCollection 2014.

19.

Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds.

Oh MY, Lee H, Kim JS, Ryu WS, Lee SH, Ko SB, Kim C, Kim CH, Yoon BW.

BMC Neurol. 2014 Jun 12;14:127. doi: 10.1186/1471-2377-14-127.

20.

Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system.

Xu Y, Lindemann P, Vega-Ramos J, Zhang JG, Villadangos JA.

J Biol Chem. 2014 Apr 4;289(14):9730-40. doi: 10.1074/jbc.M113.538041. Epub 2014 Feb 25.

Supplemental Content

Support Center